Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience
Mutualfunds logo

PHSBX Putnam Global Health Care B

  • Fund
  • PHSBX
  • Price as of: Dec 06, 2016
  • $37.57
  • + $0.01
  • + 0.03%
  • Category
  • Health & Biotech Equities

PHSBX - Profile

Vitals

  • YTD Return -13.2%
  • 3 Yr Annualized Return 6.6%
  • 5 Yr Annualized Return 15.3%
  • Net Assets $1.37 B
  • Holdings in Top 10 41.6%

52 WEEK LOW AND HIGH

$37.57
$36.32
$51.42

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.88%

SALES FEES

  • Front Load N/A
  • Deferred Load 5.00%

BROKERAGE FEES

  • Turnover 16.00%

TRADING FEES

  • Max Redemption Fee 1.00%

Min Investment

STANDARD (TAXABLE)

$0

IRA

N/A

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -13.2%
  • 3 Yr Annualized Total Return 5.9%
  • 5 Yr Annualized Total Return 15.0%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.40%
DIVIDENDS
  • Dividend Yield 0.8%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Putnam Global Health Care Fund
  • Fund Family Name Putnam
  • Inception Date Mar 01, 1993
  • Shares Outstanding N/A
  • Share Class B
  • Currency USD
  • Domiciled Country United States
  • Manager Isabel Buccellati

Fund Description

The fund invests mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that the manager believes have favorable investment potential. Under normal circumstances, it invests at least 80% of its net assets in securities of companies in the health care industries. The fund is non-diversified.

PHSBX - Performance

Return Ranking - Trailing

Period PHSBX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -13.2% -30.1% 7.4% 75.89% 4
1 Yr -11.8% -22.2% 18.4% 71.17% 4
3 Yr 6.6% * -7.5% 17.2% 66.67% 4
5 Yr 15.3% * 9.3% 23.0% 66.02% 4
10 Yr 7.2% * 6.1% 14.3% 93.94% 5

* Annualized


Return Ranking - Calendar

Period PHSBX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -10.2% -20.4% 13.8% 84.55% 5
2014 12.9% -5.9% 31.5% 64.55% 4
2013 22.8% 0.0% 65.2% 90.83% 5
2012 11.7% -5.3% 36.5% 57.28% 3
2011 -15.5% -15.5% 18.8% 95.10% 5

Total Return Ranking - Trailing

Period PHSBX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -13.2% -22.5% 7.4% 78.38% 4
1 Yr -15.5% -24.5% 10.5% 80.00% 4
3 Yr 5.9% * -14.2% 16.4% 64.81% 4
5 Yr 15.0% * 9.0% 23.0% 65.05% 4
10 Yr 7.2% * 6.1% 14.3% 90.91% 5

* Annualized


Total Return Ranking - Calendar

Period PHSBX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 8.2% -16.6% 20.7% 44.04% 3
2014 39.3% -5.8% 55.3% 25.69% 2
2013 96.1% 0.0% 398.7% 26.85% 2
2012 81.7% -5.1% 475.8% 11.00% 1
2011 -9.3% -10.2% 2296.2% 96.91% 5

NAV & Total Return History

PHSBX - Holdings

Filings data as of: Sep 30, 2016

Concentration Analysis

PHSBX Category Low Category High PHSBX % Rank Quintile
Net Assets 1.37 B 20.6 M 43.6 B 16.96% 3
Number of Holdings 92 31 345 15.18% 3
Net Assets in Top 10 622 M 9.47 M 20.9 B 17.86% 3
Weighting of Top 10 41.6% 21.8% 73.4% 23.21% 3

Top 10 Holdings

  1. Gilead Sciences Inc 5.46%
  2. Allergan PLC 6.55%
  3. Celgene Corp 5.49%
  4. Eli Lilly and Co 3.30%
  5. Bristol-Myers Squibb Company 2.97%
  6. Amgen Inc 4.02%
  7. Johnson & Johnson 3.47%
  8. Merck & Co Inc 3.39%
  9. Novartis AG 3.94%
  10. AstraZeneca PLC 2.99%

Asset Allocation

Weighting Category Low Category High PHSBX % Rank Quintile
Stocks
96.45% 82.12% 103.35% 25.00% 4
Cash
2.99% 0.00% 16.35% 10.71% 2
Other
0.56% -3.35% 10.27% 10.71% 2
Convertible Bonds
0.00% 0.00% 0.38% 3.57% 2
Preferred Stocks
0.00% 0.00% 1.35% 6.25% 3
Bonds
0.00% 0.00% 1.91% 5.36% 3

Stock Sector Breakdown

Weighting Category Low Category High PHSBX % Rank Quintile
Healthcare
92.01% 13.15% 99.87% 21.43% 4
Industrials
2.35% 0.00% 13.35% 2.68% 1
Consumer Defense
2.08% 0.00% 2.38% 1.79% 1
Financial Services
0.00% 0.00% 1.11% 7.14% 3
Technology
0.00% 0.00% 64.83% 27.68% 4
Real Estate
0.00% 0.00% 1.97% 2.68% 2
Energy
0.00% 0.00% 0.00% 0.89% 2
Communication Services
0.00% 0.00% 2.15% 2.68% 2
Utilities
0.00% 0.00% 1.10% 1.79% 2
Consumer Cyclical
0.00% 0.00% 3.21% 8.04% 3
Basic Materials
0.00% 0.00% 4.92% 5.36% 3

Stock Geographic Breakdown

Weighting Category Low Category High PHSBX % Rank Quintile
US
74.02% 60.81% 99.87% 33.93% 5
Non US
22.43% 0.00% 41.10% 3.57% 1

PHSBX - Expenses

Operational Fees

PHSBX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.88% 0.10% 4.31% 19.64% 4
Management Fee 0.62% 0.08% 1.25% 14.29% 2
12b-1 Fee 1.00% 0.00% 1.00% 1.28% 4
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

PHSBX Fees (% of AUM) Category Low Category High PHSBX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load 5.00% 1.00% 5.00% 3.13% 4

Trading Fees

PHSBX Fees (% of AUM) Category Low Category High PHSBX Rank Quintile
Max Redemption Fee 1.00% 0.75% 2.00% 4.55% 3

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

PHSBX Fees (% of AUM) Category Low Category High PHSBX Rank Quintile
Turnover 16.00% 7.00% 249.00% 26.79% 1

PHSBX - Distributions

Dividend Yield Analysis

PHSBX Category Low Category High PHSBX % Rank Quintile
Dividend Yield 0.8% 0.01% 0.94% 6.38% 1

Dividend Distribution Analysis

PHSBX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

PHSBX Category Low Category High PHSBX % Rank Quintile
Net Income Ratio -0.40% -2.22% 1.40% 33.93% 3

Capital Gain Distribution Analysis

PHSBX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

PHSBX - Managers

Isabel Buccellati

Manager

Start Date

Sep 30, 2012

Tenure

4.17

Tenure Rank

18.1%

Ms. Buccellati is an Analyst in the Global Equity Research group at Putnam, covering the health-care sector ex-U.S. She is responsible for conducting fundamental analysis and valuation of the companies in this industry and making buy/sell recommendations. She is also a Portfolio Manager of Putnam Global Health Care Fund and Putnam Global Sector Fund. Prior joined Putnam in 2012, Ms. Buccellati worked for Alliance Growth Equities, a unit of Alliance Bernstein Ltd from 2002 to 2012. Ms. Buccellati has been in the investment industry since 1994.


Samuel Cox

Manager

Start Date

Jun 07, 2016

Tenure

0.48

Tenure Rank

29.1%

Putnam Management Analyst : 2014–Present Fidelity Institutional Equity Analyst Management (f/k/a Pyramis Global Advisors) : 2010–2014


Michael Maguire

Manager

Start Date

Nov 16, 2016

Tenure

0.04

Tenure Rank

30.8%

N/A


Tenure Analysis

Category Low

0.0

Category High

19.2

Category Average

8.89

Category Mode

1.9